neuroprotexeon.com
NeuroproteXeon | Safeguarding the brain.NeuroproteXeon (NPXE) is a late clinical-stage pharmaceutical and medical device company developing the proprietary use of xenon gas, delivered via a patented inhalation device, to protect against brain cell death following acute neurologic injury. NPXE is currently preparing for a Phase III Clinical Trial in Out of Hospital Cardiac Arrest (OHCA) following a publication of positive Phase II Clinical Trial results in JAMA, March 2016. Maze, Can J Anesth/J Can Anesth. DOI 10.1007/s12630-015-0507-8.
http://www.neuroprotexeon.com/